Press release
Seed Treatment Market | Key Players are Bayer, Monsanto, Syngenta, BASF, Dow AgroSciences, DuPont, Nufarm, Germains
The seed treatment market is projected to grow at a CAGR of 10.82% from USD 6.76 Billion in 2017, to reach USD 11.31 Billion by 2022. Due to the increasing demand for integrated pest management practices to minimize pesticide usage, seed treatment products have been gaining preference for their beneficial characteristics such as the ability to combat early-season diseases and pests and their effect on crop yield.Make an Inquiry: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=503
The years considered for the study are as follows:
Base year – 2016
Estimated year – 2017
Projected year – 2022
Forecast period – 2017 to 2022
The objectives of the report:
1. Determining and projecting the size of the market with respect to type, function, crop type, application technique, and region, over the period ranging from 2017 to 2022
2. Identifying attractive opportunities in the market by determining the largest and fastest-growing segments across regions
3. Analyzing the demand-side factors on the basis of the following:
4. Impact of macro- and micro-economic factors on the market
5. Shift in demand patterns across different subsegments and regions
Cereals & grains segment is estimated to be the most important crop type for the seed treatment market
Pesticide application on cereals & grains was seen to be the highest in the US and Asia Pacific countries. Insecticides such as imidacloprid and thiamethoxam have been widely used on corn and wheat cultivation in countries such as the US, China, and India. An increase in demand has been witnessed for seed treatment from developing regions as well due to the increasing awareness about sustainable agricultural practices. Hence, the cereals & grains segment dominated the seed treatment market in 2016.
Biological seed treatment, by type, is projected to be the fastest-growing segment over the next five years
The adoption of chemicals in seed treatment is decreasing owing to the awareness of the toxicological effects associated with them and the environmental degradation caused by excessive use of these pesticides. A majority of these chemicals have been banned in a few countries across Europe, which affects the global market to a significant extent. Due to the adoption of sustainable agricultural practices in developing and developed countries, biological seed treatment has been gaining importance amongst the farmers, which can be seen from the increasing research & development activities by the key players in this market.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=503
Significant competition to capitalize on the market potential among international manufacturers in the Asia Pacific and South American regions
The rise in export quality requirements for agricultural products and increasing adoption of integrated pesticide management agricultural practices in countries such as China, India, Brazil, and Argentina are expected to drive the demand for seed treatment among the farmers in the Asia Pacific and South American regions during the forecast period. This would increase the inflow of various international manufacturers to set up their business units and distribution networks, thereby leading to strong market competition.
This report includes a study of marketing and development strategies, along with the product portfolio of leading companies. These companies include Bayer (Germany), Monsanto (US), Syngenta (Switzerland), and BASF (Germany), which are some of the well-established and financially stable players that have been operating in the industry for several years. Other players include Dow AgroSciences (US), DuPont (US), FMC (US), Sumitomo Chemical (Japan), Arysta LifeScience (US), INCOTEC (Netherlands), Nufarm (Australia), UPL (India), and Germains (UK).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
Email: sales@marketsandmarkets.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Seed Treatment Market | Key Players are Bayer, Monsanto, Syngenta, BASF, Dow AgroSciences, DuPont, Nufarm, Germains here
News-ID: 1598280 • Views: …
More Releases from MarketsandMarkets.com

Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market in terms of revenue was estimated to be worth $16.0 billion in 2024 and is poised to reach $33.8 billion by 2029, growing at a CAGR of 16.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the medical robots market is driven by the aging population and rising chronic diseases, improving reimbursement scenario, and subsequent advancements in healthcare funding & infrastructure.…

Concrete Surface Retarders Market worth $89.4 million by 2023 : Major Players ar …
The report "Concrete Surface Retarders Market by Raw Material (Organic Agents and Inorganic Agents), Type (Water-based and Solvent-based), Application (Residential and Commercial), and Region (North America, Europe, Asia Pacific) - Global Forecast to 2023", The concrete surface retarders market is projected to grow from USD 72.7 million in 2018 to USD 89.4 million by 2023, at a CAGR of 4.2% between 2018 and 2023. Increase in urban population, demand for…
Precast Concrete Market worth $174.1 billion by 2025 | Major Players are Lafarge …
The report "Precast Concrete Market by Element (Columns & Beams, Floors & Roofs, Girders, Walls & Barriers, Utility Vaults, Pipes, Paving Slabs), Construction Type, End-use Sector (Residential, Non-residential) - Global Forecast to 2025" The global precast concrete market size is projected to grow from USD 130.6 billion in 2020 to USD 174.1 billion by 2025, at a CAGR of 5.9% from 2020 to 2025. The market is projected to grow…
Fire Stopping Materials Market worth $2.4 billion by 2026 : Major Players are Hi …
The report "Fire Stopping Materials Market by Type (Sealants, Mortar, Boards, Putty &Putty Pads, Cast-in Devices), by Application (Electrical, Mechanical, Plumbing), End-Use (Commercial, Industrial & Residential), and Region - Global Forecast to 2026" MarketsandMarkets: The fire stopping materials market is projected to reach USD 2.4 billion by 2026, at a CAGR of 11.6% from USD 1.4 billion in 2021. Fire stopping is a fire protection system for sealings of any…
More Releases for MarketsandMarkets™
Biomaterials Market Worth $64.2 billion | MarketsandMarkets™
Biomaterials Market in terms of revenue was estimated to be worth $45.2 billion in 2024 and is poised to reach $64.2 billion by 2029, growing at a CAGR of 7.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. The biomaterials market is estimated to grow at a CAGR of 7.3% during the forecast period of 2024 to 2029. The important factors impacting market growth are the growing…
Cell Expansion Market Worth $26.7 billion | MarketsandMarkets™
Cell Expansion Market in terms of revenue was estimated to be worth $14.3 billion in 2024 and is poised to reach $26.7 billion by 2029, growing at a CAGR of 13.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. Some factors contributing to the growth of the global market includes increasing R&D investments in cell based research, growing focus on personalized medicine, and increasing number of strategic…
Apheresis Market Worth $3.9 billion | MarketsandMarkets™
Apheresis Market in terms of revenue was estimated to be worth $2.6 billion in 2024 and is poised to reach $3.9 billion by 2029, growing at a CAGR of 8.8% from 2024 to 2029 according to a new report by MarketsandMarkets™.
The growth in the apheresis market is driven by rise in demand for source plasma from biopharmaceutical companies, upsurging demand for blood components and favourable reimbursement for apheresis. The increasing…
Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market in terms of revenue was estimated to be worth $16.0 billion in 2024 and is poised to reach $33.8 billion by 2029, growing at a CAGR of 16.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the medical robots market is driven by the aging population and rising chronic diseases, improving reimbursement scenario, and subsequent advancements in healthcare funding & infrastructure.…
Pipette Calibrators Market Worth $391 million | MarketsandMarkets™
Pipette Calibrators Market in terms of revenue was estimated to be worth $286 million in 2024 and is poised to reach $391 million by 2029, growing at a CAGR of 6.5% from 2024 to 2029 according to a new report by MarketsandMarkets™.
The growth of this market is majorly driven by rise in genomics and proteomics research, growth in portable and handheld devices, and establishment of new research facilities by pharmaceutical…
Mice Model Market Worth $2.2 billion | MarketsandMarkets™
Mice Model Market in terms of revenue was estimated to be worth $1.5 billion in 2024 and is poised to reach $2.2 billion by 2029, growing at a CAGR of 8.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The rise in chronic diseases, such as cancer, diabetes, and cardiovascular disorders, and growing need for reliable and predictive animal models to facilitate drug discovery and development are…